Evidence map›Paper›PMID 35658627›Full record

ReviewPhysiology (Bethesda, Md.)2022

What Can an Organ-on-a-Chip Teach Us About Human Lung Pathophysiology?

Haiqing Bai, Donald E Ingber

Open access · greenAbstract readReview
In one paragraph

Review in Physiology (Bethesda, Md.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Cancer metastasisFrontiers in bioengineering and biotechnology · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. AFrontiers in cardiovascular medicine · 2024
    Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. dsRNA as broad-spectrum antiviral therapeutics.Molecular therapy. Nucleic acids · 2022
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Haiqing BaiWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts.ORCID 0000-0003-0865-1126
Donald E IngberWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts.ORCID 0000-0002-4319-6520
Boston Children's Hospital · US

Funding

Lung-on-a-Chip Disease Models for Efficacy Testing (COVID-19 Competitive Revision)UH3HL141797 · NHLBI · HARVARD UNIVERSITY · PI INGBER, DONALD E · 2019 to 2021
$5.2M
NHLBI NIH HHS UH3 HL141797
6 · The paper itself

Abstract

The intertwined relationship between structure and function has been key to understanding human organ physiology and disease pathogenesis. An organ-on-a-chip (organ chip) is a bioengineered microfluidic cell culture device lined by living cells and tissues that recapitulates organ-level functions in vitro. This is accomplished by recreating organ-specific tissue-tissue interfaces and microenvironmental biochemical and mechanical cues while providing dynamic perfusion through endothelium-lined vascular channels. In this review, we discuss how this emerging technology has contributed to the understanding of human lung structure-function relationships at the cell, tissue, and organ levels.

Indexed as

Cell Culture TechniquesLab-On-A-Chip DevicesEndothelial CellsHumansLung3-D tissue modelslung physiologymechanobiologymicrophysiological systemorgan chip

Identifiers

PMID35658627
PMCPMC9394778
OpenAlexW4281761505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.